CTLA-4 - PDFSEARCH.IO - Document Search Engine

CTLA-4
Results: 43

#	Item
21	[removed]1ug overlay on P815 and P815-B7.2 Cells Add to Reading List Source URL: www.southernbiotech.com Language: English - Date: 2014-12-15 17:46:16 Anatomy CD86 CD80 B7 Immunoglobulin superfamily CTLA-4 Fluorophore CD28 Co-stimulation Biology Immune system T cells
22	For Immediate Release Maxygen and Astellas Announce Global Agreement to Develop New Therapies for Autoimmune Diseases and Transplantation -Astellas to Receive Rights to Commercialize MAXY-4 CTLA4-Ig Candidates-Maxygen t Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-21 20:29:38 Anatomy Biology Astellas Pharma CTLA-4 Tacrolimus Immunosuppressive drug Monoclonal antibodies Autoimmunity Maxygen Immunology Immune system
23	US-Japan workshop on immunological molecular markers in oncology Add to Reading List Source URL: www.jsps.go.jp Language: English - Date: 2009-08-03 22:25:45 Immunotherapy Tumor antigen Cancer vaccine Melanoma Cancer immunotherapy Interferon Cancer research Gene therapy CTLA-4 Medicine Biology Immunology
24	Award ID: RP120108 Project Title: Improving on Anti-CTLA-4 Therapy Award Mechanism: Individual Investigator Add to Reading List Source URL: www.cprit.state.tx.us Language: English - Date: 2014-11-20 01:49:14 Anatomy CTLA-4 Cancer treatments Immunotherapy Bristol-Myers Squibb Tremelimumab Immunotransplant Immune system Medicine Immunology
25	Priming phase Effector phase MHC Add to Reading List Source URL: www.onclive.com Language: English - Date: 2014-01-24 11:51:27 Immune system Ipilimumab PD-1 Cancer vaccine PD-L1 Cancer immunotherapy CTLA-4 Melanoma Immunotherapy Medicine Immunology Biology
26	Microsoft PowerPoint - 8. Wiltrout Intro to van Dyke.pptx Add to Reading List Source URL: deainfo.nci.nih.gov Language: English - Date: 2014-02-26 10:31:15 Immune system T cells Immunotherapy Management of cancer CTLA-4 Medicine Cancer treatments Immunology
27	----------------------DOSAGE FORMS AND STRENGTHS--------------------• 250 mg single-use vial (3) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENCIA safely a Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-08-27 18:20:27 Immunology Abatacept Anakinra Rheumatoid arthritis Adalimumab Leflunomide Etanercept CTLA-4 Biologic Immunosuppressants Medicine Pharmacology
28	RESEARCH ARTICLE PULMONARY FIBROSIS Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis Add to Reading List Source URL: www.coalitionforpf.org Language: English - Date: 2013-10-18 13:29:43 T cells CD28 Lck CD86 CTLA-4 Nef CD80 CD4 Tyrosine kinase Biology Immune system Anatomy
29	----------------------DOSAGE FORMS AND STRENGTHS--------------------• 250 mg single-use vial (3) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENCIA safely a Add to Reading List Source URL: www.fda.gov Language: English Immunology Abatacept Anakinra Rheumatoid arthritis Adalimumab Leflunomide Etanercept CTLA-4 Biologic Immunosuppressants Medicine Pharmacology
30	DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville MD 20857 Add to Reading List Source URL: www.fda.gov Language: English Kidney transplantation Belatacept CTLA-4 Food and Drug Administration Medicine Organ transplants Nephrology

UPDATE